Vivek Muthu worked as a doctor in the UK National Health Service, including London’s Queen Square, the Hammersmith and Oxford University hospitals, before joining the British Medical Journal, where he helped to develop and lead a team examining the clinical value of drugs and devices.

Muthu then went on to found Bazian, a company dedicated to developing and servicing the needs of the emerging paradigm of value-based health internationally. Following its acquisition by The Economist Group, Bazian lies at the heart of The Economist Intelligence Unit’s value-based healthcare business, for which Muthu took overall leadership and strategic responsibility.

After launching EIU Healthcare, Muthu has now taken up a non-executive advisory role as chair of the business. He also sits on the steering panels for a number of UK-based initiatives in value-based health. In the past, he has additionally served as a health-care consultant to the European Bank for Reconstruction and Development.

Muthu attended the University of Oxford, the London School of Hygiene and Tropical Medicine, and the University of Cambridge. In addition to his current roles, he is a business founder and entrepreneur, business executive, independent consultant and an angel investor.

Physician, Health, Pharmaceutical, Cancer, United Kingdom, Entrepreneurship, Entrepreneurs Investing, Business Founders, Technology,